Sp82a

WELCOME AND INTRODUCTIONS

Date
May 6, 2023
Explore related products in the following collection:

Society: ASGE

LIVE STREAM SESSION

Presenters

Speaker Image for Bret Petersen
Mayo Clinic
Speaker Image for Amitabh Chak
Univ Hospital of Cleveland
Speaker Image for Jennifer Christie
Emory University School of Medicine

Tracks

Related Products

Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
SOCIETY: ASGE
Thumbnail for ACCURACY OF NON-ENDOSCOPIC SCREENING FOR BARRETT'S ESOPHAGUS (BE) AMONG PATIENTS ELIGIBLE FOR BE SCREENING
ACCURACY OF NON-ENDOSCOPIC SCREENING FOR BARRETT'S ESOPHAGUS (BE) AMONG PATIENTS ELIGIBLE FOR BE SCREENING
BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
Thumbnail for JOURNEY TO COMPLETE REMISSION OF DYSPLASIA AND INTESTINAL METAPLASIA AFTER ENDOSCOPIC ERADICATION THERAPY OF BARRETT’S ESOPHAGUS RELATED DYSPLASIA AND ADENOCARCINOMA: A COMPARATIVE ANALYSIS OF ESD VS EMR RESULTS FROM A MULTICENTER NORTH AMERICAN COHORT
JOURNEY TO COMPLETE REMISSION OF DYSPLASIA AND INTESTINAL METAPLASIA AFTER ENDOSCOPIC ERADICATION THERAPY OF BARRETT’S ESOPHAGUS RELATED DYSPLASIA AND ADENOCARCINOMA: A COMPARATIVE ANALYSIS OF ESD VS EMR RESULTS FROM A MULTICENTER NORTH AMERICAN COHORT
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…